Ignite Creation Date:
2024-05-06 @ 3:05 AM
Last Modification Date:
2024-10-26 @ 11:28 AM
Study NCT ID:
NCT02201849
Status:
COMPLETED
Last Update Posted:
2019-11-26
First Post:
2014-07-18
Brief Title:
A Study of ALKS 8700 a Monomethyl Fumarate MMF Molecule in Healthy Adults
Sponsor:
Biogen
Organization:
Biogen
Study Overview
Official Title:
A Phase 1 Study to Evaluate the Safety Tolerability and Pharmacokinetics of Oral ALKS 8700 in Healthy Adults
Status:
COMPLETED
Status Verified Date:
2019-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the safety tolerability and pharmacokinetics of ALKS 8700 a monomethyl fumerate MMF molecule
Detailed Description:
This study record was previously postedupdated by Alkermes Inc As of 29 Oct 2019 the sponsorship of the trial was transferred to Biogen along with responsibility for subsequent updates to the record
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None